Dear Colleague:
As you may be aware, APA is undertaking a process to develop clinical treatment guidelines. a Call For Nominations of individuals to serve on the panel that will develop a guideline for the treatment of depression is attached below.. Those interested in being considered to serve on this panel are asked to submit a brief statement indicating their willingness to serve and a CV. Materials are due by November 15, 2011, and should be submitted to ctg@apa.org with “depression panel” in the subject line.
You are encouraged to circulate This Call For Nominations to your contacts and professional networks.
For additional background on this APA initiative, see:
APA moves forward on developing clinical treatment guidelines
Depression and obesity will be first topics of APA clinical treatment guidelines
Respectfully,
Lynn F. Bufka, PhD
American Psychological Association
Mary G. Hardiman, Director of Board Operations Governance Operations email: mhardiman@apa.org | www.apa.org |
|
| |
P Please consider the environment before printing this email. | |
Click on this link to unsubscribe from this list UNSUBSCRIBE
An email will automatically open with "Unsubscribe" in the subject area. Just Send the message, as is, to unsubscribe from this list..
American Psychological Association
Call for Nominations
Clinical Treatment Guideline Development Panel
Depressive Disorders Across the Lifespan
The American Psychological Association’s Advisory Steering Committee for the Development of Clinical Treatment Guidelines is seeking nominations of individuals to serve on a panel to develop a clinical treatment guideline for depressive disorders across the lifespan. Individuals are encouraged to self-nominate and nominations from other individuals and groups are also invited. Nominees who will enhance the diversity of the development panels are particularly encouraged to apply.
The development panel will be composed of at least seven members. Members ideally serve on only one active APA guideline development panel at a time although they may serve on more than one over the course of time. The development panels will be led by a chair. The selection of the chair will be made by the Advisory Steering Committee. The development panel may include members from disciplines other than psychology. It is expected that the panel will take approximately two years to complete its work.
The development panels will consist of at least:
1. Three content experts in the area of depressive disorders
2. One full-time generalist practitioner
3. One patient/ consumer advocate
4. One biostatistician or methodologist
Among the content experts, a breadth of perspectives will be represented and include both experts who are primarily researchers and those who are primarily practitioners. Task force members should have knowledge of treatment issues related to age (including children and older adults) and other dimensions of diversity (such as race/ethnicity, socioeconomic status, culture, gender, sexuality, physical and mental abilities). It is anticipated that task force members will collectively have experience working with a broad range of populations and in a broad range of settings. Membership in APA is not a requirement to serve on the panel.
Background or expertise in one or more of the following areas may be useful to the panel:
- Clinical treatment guidelines development
- Comparative effectiveness research
- Systematic reviews
- Experience with clinical trials
- Contemporary methods for evaluation of psychological and behavioral interventions
- Dissemination/implementation research
- Relevant expertise in research design and statistical analysis
- Experience applying clinical treatment guidelines in practice settings
- Experience applying evidence-based practices in clinical settings
- Direct provision of psychological care in diverse practice settings or with diverse populations
- Patient/ consumer perspective
- Federal agency policies and programs related to guidelines
- Health care systems finance or administration
- Public health research and applications
- Public and community health delivery systems
The development panel will write the guideline for the treatment of depressive disorders based on systematic reviews of the research literature. The panel will not conduct the systematic reviews itself but will develop the questions that guide the systematic reviews in collaboration with the Advisory Steering Committee and potentially other consultants. The guideline will include treatment recommendations and indications of the strength of the evidence for each recommendation in accordance with procedures developed by the Advisory Steering Committee and consistent with emerging best practices in treatment guidelines development. Progress reports will be made to the Advisory Steering Committee and the APA Board of Directors and governance groups on a regular basis.
The Advisory Steering Committee will review candidate materials and provide a final list of qualified candidates for the development panel to the Board of Directors for appointment.
Letters of nomination should clearly describe the candidate's specific expertise and qualifications related to the criteria above. Nomination materials should include a letter from the nominee indicating willingness to serve for at least two years, a brief statement of the nominee's qualifications, and a current curriculum vitae. Development panel members are expected to travel to Washington, DC, for at least two face-to-face meetings yearly and commit additional time and effort to the panel in between these meetings. Current members of the APA governance groups BPA, BSA and CAPP are not eligible to serve.
Nominations and supporting materials should be sent via email to the APA Clinical Treatment Guidelines mailbox (ctg@apa.org) by November 15, 2011.
Note: Candidates not selected for this development panel may be nominated for future panels.
Additional background:
APA moves forward on developing clinical treatment guidelines
Depression and obesity will be first topics of APA clinical treatment guidelines
